Nuvalent

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. operates as a preclinical stage biopharmaceutical company. The company creates precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. 

CEO
James R. Porter
CEOJames R. Porter
Employees
40
Employees40
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
40
Employees40

NUVL Key Statistics

Market cap
944.05M
Market cap944.05M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
173.65K
Average volume173.65K
High today
$20.66
High today$20.66
Low today
$18.85
Low today$18.85
Open price
$19.92
Open price$19.92
Volume
381.20K
Volume381.20K
52 Week high
$31.43
52 Week high$31.43
52 Week low
$7.09
52 Week low$7.09

NUVL Earnings

-$3.17
-$2.11
-$1.06
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.